ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Additional Information for 20 May Announcement
|
|
MisterMister
|
53 |
15K |
0 |
04/06/20 |
04/06/20 |
ASX - By Stock
|
53
|
15K
|
0
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Additional Information for 20 May Announcement
|
|
MisterMister
|
53 |
15K |
1 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
53
|
15K
|
1
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Additional Information for 20 May Announcement
|
|
MisterMister
|
53 |
15K |
5 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
53
|
15K
|
5
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Additional Information for 20 May Announcement
|
|
MisterMister
|
53 |
15K |
1 |
03/06/20 |
03/06/20 |
ASX - By Stock
|
53
|
15K
|
1
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Additional Information for 20 May Announcement
|
|
MisterMister
|
53 |
15K |
0 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
53
|
15K
|
0
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Additional Information for 20 May Announcement
|
|
MisterMister
|
53 |
15K |
2 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
53
|
15K
|
2
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Additional Information for 20 May Announcement
|
|
MisterMister
|
53 |
15K |
7 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
53
|
15K
|
7
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Additional Information for 20 May Announcement
|
|
MisterMister
|
53 |
15K |
4 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
53
|
15K
|
4
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Additional Information for 20 May Announcement
|
|
MisterMister
|
53 |
15K |
0 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
53
|
15K
|
0
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Additional Information for 20 May Announcement
|
|
MisterMister
|
53 |
15K |
0 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
53
|
15K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
MisterMister
|
4.2K |
3.8M |
0 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
4.2K
|
3.8M
|
0
|
|
ASX - By Stock
|
PER |
Re:
ATL1102 blockbuster drug to replace steroids for the treatment of Inflammation.
|
|
MisterMister
|
92 |
32K |
16 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
92
|
32K
|
16
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trial Met Primary & Exceeded Secondary Endpoint Expectations
|
|
MisterMister
|
222 |
81K |
5 |
22/05/20 |
22/05/20 |
ASX - By Stock
|
222
|
81K
|
5
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Commercial Update
|
|
MisterMister
|
17 |
4.8K |
0 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
17
|
4.8K
|
0
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Commercial Update
|
|
MisterMister
|
17 |
4.8K |
1 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
17
|
4.8K
|
1
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Commercial Update
|
|
MisterMister
|
17 |
4.8K |
0 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
17
|
4.8K
|
0
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Commercial Update
|
|
MisterMister
|
17 |
4.8K |
2 |
20/05/20 |
20/05/20 |
ASX - By Stock
|
17
|
4.8K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: BLOCK TRADE TO INSTITUTIONAL INVESTORS
|
|
MisterMister
|
193 |
78K |
1 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
193
|
78K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: BLOCK TRADE TO INSTITUTIONAL INVESTORS
|
|
MisterMister
|
193 |
78K |
1 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
193
|
78K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: BLOCK TRADE TO INSTITUTIONAL INVESTORS
|
|
MisterMister
|
193 |
78K |
1 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
193
|
78K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
MisterMister
|
4.2K |
3.8M |
0 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
4.2K
|
3.8M
|
0
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Business Update and Appendix 4C
|
|
MisterMister
|
6 |
2.4K |
0 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
6
|
2.4K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
New orphan drug designation
|
|
MisterMister
|
46 |
17K |
0 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
46
|
17K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
New orphan drug designation
|
|
MisterMister
|
46 |
17K |
1 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
46
|
17K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
MisterMister
|
4.1K |
1.9M |
0 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
4.1K
|
1.9M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PARADIGM TO HOST INVESTOR CALL
|
|
MisterMister
|
108 |
43K |
1 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
108
|
43K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Its been done before.
|
|
MisterMister
|
121 |
42K |
2 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
121
|
42K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Change of Director's Interest Notice
|
|
MisterMister
|
29 |
12K |
0 |
16/03/20 |
16/03/20 |
ASX - By Stock
|
29
|
12K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Change of Director's Interest Notice
|
|
MisterMister
|
29 |
12K |
0 |
16/03/20 |
16/03/20 |
ASX - By Stock
|
29
|
12K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Change of Director's Interest Notice
|
|
MisterMister
|
29 |
12K |
1 |
16/03/20 |
16/03/20 |
ASX - By Stock
|
29
|
12K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
MisterMister
|
4.1K |
1.9M |
0 |
13/03/20 |
13/03/20 |
ASX - By Stock
|
4.1K
|
1.9M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
MisterMister
|
4.1K |
1.9M |
0 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
4.1K
|
1.9M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
MisterMister
|
4.1K |
1.9M |
1 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
4.1K
|
1.9M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
MisterMister
|
4.1K |
1.9M |
0 |
11/03/20 |
11/03/20 |
ASX - By Stock
|
4.1K
|
1.9M
|
0
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Response to ASX Appendix 4C Query
|
|
MisterMister
|
15 |
90K |
6 |
05/03/20 |
05/03/20 |
ASX - By Stock
|
15
|
90K
|
6
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Response to ASX Appendix 4C Query
|
|
MisterMister
|
15 |
90K |
3 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
15
|
90K
|
3
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Response to ASX Appendix 4C Query
|
|
MisterMister
|
15 |
90K |
4 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
15
|
90K
|
4
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl develops clinical trial prediction software using AI
|
|
MisterMister
|
21 |
27K |
1 |
24/02/20 |
24/02/20 |
ASX - By Stock
|
21
|
27K
|
1
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl develops clinical trial prediction software using AI
|
|
MisterMister
|
21 |
27K |
2 |
21/02/20 |
21/02/20 |
ASX - By Stock
|
21
|
27K
|
2
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl partners with hummun
|
|
MisterMister
|
2 |
1.6K |
0 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
2
|
1.6K
|
0
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl - Business Update and Appendix 4C
|
|
MisterMister
|
12 |
4.4K |
0 |
01/02/20 |
01/02/20 |
ASX - By Stock
|
12
|
4.4K
|
0
|
|
ASX - By Stock
|
OPL |
Re:
New Thread for OPYL
|
|
MisterMister
|
27 |
12K |
0 |
31/01/20 |
31/01/20 |
ASX - By Stock
|
27
|
12K
|
0
|
|
ASX - By Stock
|
OPL |
Re:
New Thread for OPYL
|
|
MisterMister
|
27 |
12K |
0 |
29/01/20 |
29/01/20 |
ASX - By Stock
|
27
|
12K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
MisterMister
|
3.3K |
2.5M |
0 |
19/12/19 |
19/12/19 |
ASX - By Stock
|
3.3K
|
2.5M
|
0
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
MisterMister
|
3.3K |
2.5M |
11 |
19/12/19 |
19/12/19 |
ASX - By Stock
|
3.3K
|
2.5M
|
11
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive results reaffirm plans to advance ATL1102 to P2b
|
|
MisterMister
|
87 |
47K |
21 |
19/12/19 |
19/12/19 |
ASX - By Stock
|
87
|
47K
|
21
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive results reaffirm plans to advance ATL1102 to P2b
|
|
MisterMister
|
87 |
47K |
4 |
18/12/19 |
18/12/19 |
ASX - By Stock
|
87
|
47K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive results reaffirm plans to advance ATL1102 to P2b
|
|
MisterMister
|
87 |
47K |
1 |
17/12/19 |
17/12/19 |
ASX - By Stock
|
87
|
47K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive results reaffirm plans to advance ATL1102 to P2b
|
|
MisterMister
|
87 |
47K |
9 |
17/12/19 |
17/12/19 |
ASX - By Stock
|
87
|
47K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Combined Therapies for DMD
|
|
MisterMister
|
189 |
91K |
2 |
16/11/19 |
16/11/19 |
ASX - By Stock
|
189
|
91K
|
2
|
|